SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-21-041409
Filing Date
2021-12-13
Accepted
2021-12-13 17:28:22
Documents
12

Document Format Files

Seq Description Document Type Size
1 DEFA14A brhc10031793_defa14a.htm DEFA14A 115844
2 brhc10031793_defa14aslide1.jpg GRAPHIC 132159
3 brhc10031793_defa14aslide2.jpg GRAPHIC 211163
4 brhc10031793_defa14aslide3.jpg GRAPHIC 155960
5 brhc10031793_defa14aslide4.jpg GRAPHIC 112489
6 brhc10031793_defa14aslide5.jpg GRAPHIC 149768
7 brhc10031793_defa14aslide6.jpg GRAPHIC 73058
8 brhc10031793_defa14aslide7.jpg GRAPHIC 96337
9 image0.jpg GRAPHIC 44721
10 image00001.jpg GRAPHIC 67582
11 image00004.jpg GRAPHIC 4168
12 image00005.jpg GRAPHIC 970
  Complete submission text file 0001140361-21-041409.txt   1561977
Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-453-7200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-31161 | Film No.: 211489000
SIC: 2834 Pharmaceutical Preparations